In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...